WellTheory, a virtual care platform for autoimmune disease, has announced a new women’s health program focused on addressing hormonal conditions including PCOS, endometriosis, postpartum, hypothyroidism, perimenopause, and menopause. The program aims to support women dealing with the interconnected challenges of autoimmune disease and hormone imbalances.
The initiative comes in response to significant gender disparities in autoimmune disease, with women making up 80 percent of the more than 50 million Americans affected. Some conditions are up to 16 times more common in women, and research shows that hormonal shifts during puberty, pregnancy, postpartum, and menopause can impact immune system activity.
“As a woman who began suffering with an autoimmune disease in my mid-20’s, who went on to learn that multiple hormonal issues were one of the root causes of my diagnosis, it was important to create a program aimed at helping other women navigate this oftentimes long and frustrating journey to get find solutions,” said Ellen Rudolph, CEO and Co-Founder of WellTheory. “As women’s health remains underfunded and overlooked, WellTheory is dedicated to bringing much needed attention and personalized support to those struggling most and will continue to be at the forefront of working to reverse the autoimmune epidemic — which goes hand in hand with the women’s health crisis.”
Currently, women comprise 71 percent of WellTheory’s patient population, with over 30 percent experiencing hormonal-related conditions alongside their autoimmune disease. The company’s program, built on over a decade of clinical evidence, has already shown results including increased energy, improved muscle strength, reduced anxiety, improved digestion, better sleep, and more stable moods.
